Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Calfactant
Drug ID BADD_D00342
Description Calfactant is a sterile, non-pyrogenic lung surfactant intended for intratracheal instillation. It is an off-white suspension of an extract of natural surfactant from calf lungs suspended in 0.9% saline. Each milliliter of calfactant contains 35mg of phospholipids (including 26 mg phosphatidylcholine of which 16 mg is disaturated phosphatidylcholine) and 0.65mg of proteins including surfactant-associated proteins B and C. Calfactant is approved for use in the United States of America. It is used to prevent or treat respiratory distress syndrome in premature infants with lung surfactant deficiency. Calfactant has been shown to decrease the incidence of respiratory distress syndrome, mortality due to respiratory distress syndrome, and air leaks associated with respiratory distress syndrome in clinical trials. It adsorbs to the air:fluid interface in the lungs and works to reduce surface tension, in a manner similar to endogenous pulmonary surfactant.
Indications and Usage Calfactant is indicated for prophylaxis therapy to prevent respiratory distress syndrome (RDS) in premature infants <29 weeks of gestational age with low lung surfactant and at high risk for RDS. Calfactant therapy is also indicated for the treatment of respiratory distress syndrome in infants 72 hours or less of age with RDS confirmed by clinical and radiologic findings and requiring endotracheal intubation.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB06415
KEGG ID D03317
MeSH ID C117342
PubChem ID Not Available
TTD Drug ID D03MUT
NDC Product Code 61938-456
UNII Q4K217VGA9
Synonyms calfactant | bovine lung surfactant | Infasurf
Chemical Information
Molecular Formula Not Available
CAS Registry Number 183325-78-2
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Apnoea22.02.01.001--
Bradycardia02.03.02.002---
Cyanosis02.11.04.004; 22.02.02.007; 23.06.04.005; 24.03.01.007--
Haemorrhage intracranial17.08.01.008; 24.07.04.003--
Intraventricular haemorrhage17.08.01.017; 24.07.04.008---
Patent ductus arteriosus02.08.01.001; 03.07.01.001; 24.03.03.002---
Pulmonary haemorrhage22.12.01.009; 24.07.01.016--
Pulmonary interstitial emphysema syndrome22.01.02.012---
Sepsis11.01.11.003--
Necrotising colitis07.08.01.013---
Periventricular leukomalacia17.13.02.005; 18.04.07.003---
Obstructive airways disorder22.03.01.011---
Endotracheal intubation complication08.07.02.001; 12.02.07.002; 22.04.07.001---
Mechanical ventilation25.13.01.001---
Pulmonary air leakage12.02.07.004; 18.04.09.001; 22.01.02.011---
The 1th Page    1    Total 1 Pages